| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |